Evidence map›Paper›PMID 30970111›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2019

Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital.

Hectorina Rodulfo, Anlenys Arcia, Aldo Hernández, Elvia Michelli, Dianny Del Valle Martinez, Militza Guzman, Ashutoch Sharma, Marcos De Donato

Open access · diamondAbstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Enzyme Production and Inhibitory Potential ofAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. New Variants of PseudomonasMicroorganisms · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hectorina RodulfoTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico.ORCID http://orcid.org/0000-0002-6678-5184
Anlenys ArciaUniversidad de Oriente, Laboratório de Genética Molecular, Cumaná, Venezuela.
Aldo HernándezTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico.ORCID http://orcid.org/0000-0003-0682-3959
Elvia MichelliUniversidad de Oriente, Laboratório de Genética Molecular, Cumaná, Venezuela.
Dianny Del Valle MartinezHospital Universitario Antonio Patricio de Alcalá, Laboratório de Bacteriología Clínica, Cumaná, Venezuela.
Militza GuzmanUniversidad de Oriente, Laboratório de Genética Molecular, Cumaná, Venezuela.
Ashutoch SharmaTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico.
Marcos De DonatoTecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico.ORCID http://orcid.org/0000-0001-8860-6020
Universidad de Oriente · VETecnológico de Monterrey · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug resistance (MDR), virulence and transferable elements potentiate Pseudomonas aeruginosa's role as an opportunistic pathogen creating a high risk for public health. In this study, we evaluated the possible association of multidrug resistance, virulence factors and integrons with intrahospital P. aeruginosa strains isolated from patients at Cumana hospital, Venezuela. Relevant clinical-epidemiological data were collected to study 176 strains (2009-2016) isolated from different hospital units. Bacterial resistance was classified as susceptible, low-level resistant (LDR), multidrug resistant (MDR) and extensively drug-resistant (XDR). Most strains produced pyoverdine, DNase, gelatinase and hemolysin. Around 73% of the strains showed some type of movement. MDR and XDR strains increased from 2009 (24.2% and 4.8%, respectively) to 2016 (53.1% and 18.8%); while LDR decreased from 64.5% to 6.3%. The exoU and exoS genes were found in a significant number of strains (38.1 and 7.4%, respectively). Class I integrons were detected in 35.8% of the strains and the frequency was associated with resistance (42.9, 22.4, 41.4 and 61.9%, for susceptible, LDR, MDR and XDR, respectively). The MDR/XDR strains were positively associated with hemolysins and exoU, but negatively associated with bacterial twitching. MDR/XDR phenotypes were also associated with the Intensive Care Unit (ICU), septicemia, bronchial infection and diabetic foot ulcers, as well as long hospital stay (≥10 days) and previous antimicrobial treatment. High frequency of MDR/XDR strains and their association with class I integrons and virulence factors can increase the infection potential, as well as morbidity and mortality of patients attending this hospital and could spread infection to the community, creating a health risk for the region.

Indexed as

Anti-Bacterial AgentsBiofilmsDrug Resistance, Multiple, BacterialHospitals, UniversityHumansIntegronsIntensive Care UnitsMicrobial Sensitivity TestsPhenotypePseudomonas aeruginosaPseudomonas InfectionsVenezuelaVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factors

Identifiers

PMID30970111
PMCPMC6453424
OpenAlexW2933536085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.